Association between obesity and cervical intraepithelial neoplasia: results from a case control study in south western Uganda
Tóm tắt
Though obesity has been said to be associated with a number of malignancies including cervical cancer, its association with cervical intraepithelial neoplasia (CIN) is still a contentious issue. This study was designed to determining the prevalence and association between obesity and CIN.
This was an unmatched case control study, involving women with cervical intraepithelial neoplasia (cases) and those negative for intraepithelial lesions or malignancy (controls) at the cervical cancer clinic of Mbarara Regional Referral Hospital, in south-western Uganda, between April and November 2022. Cases and controls provided written informed consent and were recruited in a ratio of 1:1. Cases were identified by visual inspection with acetic acid (VIA) and subsequent confirmation with cytology and/or histology. Demographic information was collected using an enrolment form and height, weight and waist circumference were recorded. We calculated body mass index (BMI) and identified obese women as those with body mass index of ≥ 30 kg/m2 from both case and control groups. Central obesity was defined as waist: height ration of ≥ 0.5. Data was analysed using STATA version 17. Categorical variables were analysed using proportions, chi-square and logistic regression analysis to determine association between obesity and CIN. Our level of statistical significance was set at ≤ 0.05.
The prevalence of general and central obesity among cases was 25.5% (24/94) and 0% (0/94) respectively while the prevalence of general and central obesity among controls was 33.3% (37/111) and 0% (0/111) respectively. There was an increased prevalence of general obesity among women with low grade squamous intraepithelial lesions (LSIL). However, there was no statistically significant association between general obesity and CIN. Factors associated with general obesity included residing in Mbarara city (AOR 2.156, 95%CI 1.085–4.282, P-value 0.028), age group of 31–45 years (AOR 2.421, 95%CI 1.577–9.705, P-value 0.003) and ≥ 46 years (AOR 1.971, 95%CI 1.022–11.157, P-value 0.046).
We observed an increased prevalence of general obesity among women with LSIL. However, there was no association between obesity and CIN. Factors associated with general obesity included residing in Mbarara city, and being in the age groups of 31–40 and ≥ 46 years. This highlights the need to rethink management of CIN to control other non-communicable diseases that could arise due to general obesity.
Từ khóa
Tài liệu tham khảo
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.
Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J et al. ICO/IARC information centre on HPV and cancer (HPV information centre).Human papillomavirus and related diseases in the world Summary Report. 2019;17(6).
Organization WH. Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. 2020.
Anorlu RI. Cervical cancer: the sub-saharan african perspective. Reprod Health Matters. 2008;16(32):41–9.
Denny L, Quinn M, Sankaranarayanan R. Screening for cervical cancer in developing countries. Vaccine. 2006;24:71–S7.
Sankaranarayanan R. Screening for cancer in low-and middle-income countries. Annals of global health. 2014;80(5):412–7.
Botha H, Cooreman B, Dreyer G, Lindeque G, Mouton A, Guidozzi F, et al. Cervical cancer and human papillomavirus: south african guidelines for screening and testing: clinical guidelines. South Afr J Gynaecol Oncol. 2010;2(1):23–6.
Stelzle D, Tanaka LF, Lee KK, Khalil AI, Baussano I, Shah AS, et al. Estimates of the global burden of cervical cancer associated with HIV. 2021;9(2):e161–e9.
Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, et al. HPV vaccination and the risk of invasive cervical cancer. 2020;383(14):1340–8.
Di Tucci C, Schiavi MC, Faiano P, D’Oria O, Prata G, Sciuga V et al. Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers. 2018;128:30–42.
Bogani G, Raspagliesi F, Sopracordevole F, Ciavattini A, Ghelardi A, Simoncini T et al. Assessing the long-term role of vaccination against hpv after loop electrosurgical excision procedure (Leep): A propensity-score matched comparison. 2020;8(4):717.
Bogani G, Sopracordevole F, Di Donato V, Ciavattini A, Ghelardi A, Lopez S et al. High-risk HPV-positive and-negative high-grade cervical dysplasia: Analysis of 5-year outcomes. 2021;161(1):173–8.
Bogani G, Lalli L, Sopracordevole F, Ciavattini A, Ghelardi A, Simoncini T et al. Development of a nomogram predicting the risk of persistence/recurrence of cervical dysplasia. 2022;10(4):579.
Taye BT, Mihret MS, Muche HA. Risk factors of precancerous cervical lesions: the role of women’s socio-demographic, sexual behavior and body mass index in Amhara region referral hospitals; case-control study. PLoS ONE. 2021;16(3):e0249218.
Teame H, Addissie A, Ayele W, Hirpa S, Gebremariam A, Gebreheat G, et al. Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: a case control study. PLoS ONE. 2018;13(1):e0191506.
Kebede HM, Hailay SB, Teklehaymanot HA. Prevalence of precancerous cervical lesion and associated factors among women in North Ethiopia. J Public Health Epidemiol. 2017;9(3):46–50.
Ntekim A. Cervical cancer in sub Sahara Africa. Top Cerv cancer advocacy Prev. 2012;4:54–9.
Denny L. Cervical cancer prevention: new opportunities for primary and secondary prevention in the 21st century. Int J Gynecol Obstet. 2012;119:80–S4.
Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief, no 360. National Center for Health Statistics. 2020(360).
Poorolajal J, Jenabi E. The association between BMI and cervical cancer risk: a meta-analysis. Eur J Cancer Prev. 2016;25(3):232–8.
Benedetto C, Salvagno F, Canuto EM, Gennarelli G. Obesity and female malignancies. Best Pract Res Clin Obstet Gynecol. 2015;29(4):528–40.
Eifel PJ, Jhingran A, Bodurka DC, Levenback C, Thames H. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol. 2002;20(17):3651–7.
Gu W, Chen C, Zhao K-N. Obesity-associated endometrial and cervical cancers. Front Bioscience-Elite. 2013;5(1):109–18.
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. BMJ. 2007;335(7630):1134.
Frumovitz M, Jhingran A, Soliman PT, Klopp AH, Schmeler K, Eifel PJ. Morbid obesity as an independent risk factor for disease-specific mortality in women with cervical cancer. Obstet Gynecol. 2014;124(6):1098.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348(17):1625–38.
Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5· 24 million UK adults. The Lancet. 2014;384(9945):755–65.
Song Y-M, Sung J, Ha M. Obesity and risk of cancer in postmenopausal korean women. J Clin Oncol. 2008;26(20):3395–402.
Feng Y-H. The association between obesity and gynecological cancer. Gynecol Minim Invasive Therapy. 2015;4(4):102–5.
Wee CC, Huang A, Huskey KW, McCarthy EP. Obesity and the likelihood of sexual behavioral risk factors for HPV and cervical cancer. Obesity. 2008;16(11):2552–5.
Ahn HK, Shin JW, Ahn HY, Park C-Y, Lee NW, Lee JK, et al. Metabolic components and recurrence in early-stage cervical cancer. Tumor Biology. 2015;36(3):2201–7.
Kim M, Kim I-H, Lim MK, Kim Y, Park B. Increased prevalence of metabolic syndrome in adult cancer survivors: asian first report in community setting. Cancer Epidemiol. 2019;58:130–6.
Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. john wiley & sons; 2013.
Onis Md, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann JJBotWhO. Development of a WHO growth reference for school-aged children and adolescents. 2007;85(9):660–7.
Weir CB, Jan A. BMI classification percentile and cut off points. 2019.
Garvey WT, Mechanick JI. Proposal for a scientifically correct and medically actionable disease classification system (ICD) for obesity. Obesity. 2020;28(3):484–92.
Cohen SS, Park Y, Signorello LB, Patel AV, Boggs DA, Kolonel LN, et al. A pooled analysis of body mass index and mortality among African Americans. PLoS ONE. 2014;9(11):e111980.
Balasubramaniam SD, Balakrishnan V, Oon CE, Kaur G. Key molecular events in cervical cancer development. Medicina. 2019;55(7):384.
Prompakay R, Promthet S, Kamsa-Ard S, Suwanrungruang K, Wiangnon S, Bradshaw P. Relationship between the body mass index and abnormal pap smears. Asian Pac J Cancer Prev. 2013;14(9):5503–6.
Lacey JV Jr, Swanson CA, Brinton LA, Altekruse SF, Barnes WA, Gravitt PE, et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2003;98(4):814–21.
Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211–9.
Kitahara CM, Flint AJ, Berrington de Gonzalez A, Bernstein L, Brotzman M, MacInnis RJ, et al. Association between class III obesity (BMI of 40–59 kg/m2) and mortality: a pooled analysis of 20 prospective studies. PLoS Med. 2014;11(7):e1001673.
Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355(8):763–78.
Zhang Q, Wang Y. Trends in the association between obesity and socioeconomic status in US adults: 1971 to 2000. Obes Res. 2004;12(10):1622–32.
Anekwe CV, Jarrell AR, Townsend MJ, Gaudier GI, Hiserodt JM, Stanford FC. Socioeconomics of obesity. Curr Obes Rep. 2020;9(3):272–9.
Okoro SO, Ajah LO, Nkwo PO, Aniebue UU, Ozumba BC, Chigbu CO. Association between obesity and abnormal papanicolau (pap) smear cytology results in a resource-poor nigerian setting. BMC Womens Health. 2020;20(1):1–8.
Kizer NT, Thaker PH, Gao F, Zighelboim I, Powell MA, Rader JS, et al. The effects of body mass index on complications and survival outcomes in patients with cervical carcinoma undergoing curative chemoradiation therapy. Cancer. 2011;117(5):948–56.
Lee JK, So KA, Piyathilake CJ, Kim MK. Mild obesity, physical activity, calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer. PLoS ONE. 2013;8(6):e66555.
Clarke MA, Fetterman B, Cheung LC, Wentzensen N, Gage JC, Katki HA, et al. Epidemiologic evidence that excess body weight increases risk of cervical cancer by decreased detection of precancer. J Clin Oncol. 2018;36(12):1184.
Maruthur NM, Bolen SD, Brancati FL, Clark JM. The association of obesity and cervical cancer screening: a systematic review and meta-analysis. Obesity. 2009;17(2):375–81.